Infectious Disease Control
FDI - Dental disaster: One year after first lockdowns dentists around the world confront the consequences of the COVID-19 pandemic on people's oral health: higher incidence of tooth decay and more advanced gum disease
GENEVA, March 18, 2021 /PRNewswire/ -- Ahead of World Oral Health Day
Merck Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies
DARMSTADT, Germany, March 17, 2021 /PRNewswire/ -- Merck, a leading science and technology company, will add a single-use assembly production unit at its Life Science Center in Molsheim,France. With the € 25 million investment, the company is accelerating its European expansion plans for this key...
GenScript and G42 Healthcare announce collaboration to provide innovative solutions to fight against COVID-19
SINGAPORE, March 17, 2021 /PRNewswire/ -- GenScript Biotech Singapore, a subsidiary of GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world leading biotechnology company, and G42 Healthcare, a leading healthcare technology company, based in the UAE, today announced they have ...
The Public Health Agency of Canada and the University of Manitoba recruiting a scientific leader to head Canada's National Microbiology Laboratory
WINNIPEG, MB, March 16, 2021 /PRNewswire/ -- The Public Health Agency of Canada and theUniversity of Manitoba are collaborating in the recruitment of a scientific leader in infectious disease laboratory science to leadCanada's National Microbiology Laboratory (NML). This individual will hold a fa...
Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials
- 100% protection against severe disease - Final analysis in U.K. trial confirms 96% efficacy against original strain of COVID-19 - Efficacy against variants confirmed in U.K. and South Africa GAITHERSBURG, Md., March 12, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnolog...
Largest-ever installation of LightAir Health+
STOCKHOLM, March 11, 2021 /PRNewswire/ -- LightAir has received an order for a large installation of air purifiers and virus inhibitors within its Professional Solutions segment. The American International School ofBucharest has ordered an air purification capacity of approximately100,000 m3/h, w...
Zymo Research Receives 510(k) Clearance for its Collection/Transport Device for COVID-19
IRVINE, Calif., March 11, 2021 /PRNewswire/ -- Zymo Research announced today the U.S. Food and Drug Administration (FDA) has cleared itsDNA/RNA Shield™ Collection Tube as a Class II medical device. The FDA's 510(k) clearance allows the product to be used as an In-vitro Diagnostic (IVD) device for...
Lianhua Qingwen -- The Leading TCM In Global Anti-Pandemic Programs
SHIJIAZHUANG, China, March 11, 2021 /PRNewswire/ -- As an epitome of the Chinese civilization, traditional Chinese medicine or TCM, and western medicine, reinforce each other to protect and improve people's health. Since the outbreak of the COVID-19 pandemic,China has been strengthening the inte...
First pocket inhaler for Covid-19 and other viral mutations: DG-Nika AG - a new approach to therapy & proactive protection from the pandemic
BUOCHS, Switzerland, March 11, 2021 /PRNewswire/ -- The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-...
First pocket inhaler for Covid-19 and other viral mutations: DG-Nika AG - a new approach to therapy & proactive protection from the pandemic
BUOCHS, Switzerland, March 11, 2021 /PRNewswire/ -- The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Ni...
HKBN Enterprise Solutions Offers Prompt Support to Catering Businesses with PHILIPS UV-C Air Disinfection Device
HONG KONG, March 9, 2021 /PRNewswire/ -- Understanding the special operational needs of catering businesses during COVID, HKBN Enterprise Solutions ("HKBNES") has teamed up with Signify (formerly Philips Lighting) to bring to the market – in particular restaurants and catering premises –PHILIPS U...
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 5, 2021 /PRNewswire/ -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative ...
Zymo Research Offers Community-Wide SARS-CoV-2 Detection and Variant Tracking with the Environ™ COVID-19 Wastewater Testing Service
IRVINE, Calif., March 4 2021 /PRNewswire/ -- Zymo Research announced today the launch of itsEnviron™ COVID-19 Wastewater Testing Service. This service facilitates daily community-wide monitoring of COVID-19 cases and variants from a single wastewater sample. Daily case estimates and detected SARS...
e-condLIFE: Cost of human life and business shut down can be minimized with this new prevention technology
* A smarter preventative way to keep family members safe * Peace of mind for staff and customers that the premises are being disinfected 24 hours KUALA LUMPUR, Malaysia, March 3, 2021 /PRNewswire/ -- Since launching inJune 2020, e-condLIFE has been well received and proven to be effective. Dr...
BioVaxys Expanding Technology Platform To Address Emerging SARS-CoV-2 Variants
BVX-0320 and Covid-T to have capability to address UK, Brazilian and South African Virus Variants VANCOUVER, B.C., March 1, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF)("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer app...
VLP BioTech, Inc. Announces an Immunotherapy Designed for the Treatment of Chronic HBV/HDV Infections
- VLP BioTech Has Developed a Vaccine-Based Viral-Entry-Inhibitor for the Treatment of Chronic HBV/HDV. - The Vaccine-Based Treatment Has Significant Advantages Compared to a Peptide-Based, Entry-Inhibitor (Hepcludex). SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- VLP BioTech, Inc., a private, pre...
Week's Top Stories
Most Reposted
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 328 media titles]
2026-02-19 14:30NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00Vitafoods Asia 2026 Expands by 30%: A Bigger, More Dynamic Trade Event with Exciting New Features & Increased International Participation
[Picked up by 286 media titles]
2026-02-23 10:09Little Artists Art Studio, Singapore Shines at Art Capital 2026
[Picked up by 280 media titles]
2026-02-17 19:12Yiwu in the Year of the Horse: Understanding the Chinese Expression of a "Global Community"
[Picked up by 260 media titles]
2026-02-19 11:15